IDEAYA Biosciences Știri Eulerpool

IDEAYA Biosciences Eulerpool News

IDEAYA Biosciences Știri Acțiune

IDEAYA Biosciences este urmărit de numeroși jurnaliști și investitori din întreaga lume. Cele mai recente IDEAYA Biosciences știri le adunăm aici.

• 10 iulie ·

  Yahoo
  IDEAYA Announces Pricing of Public Offering
• 9 iulie ·

  Yahoo
  IDEAYA Biosciences reports positive data from Phase II trial of cancer treatment
• 8 iulie ·

  SeekingAlpha
  Ideaya Biosciences: Poised For Success In Bladder And Lung Cancer?
• 8 iulie ·

  Yahoo
  IDEAYA Announces Positive Interim Phase 2 Monotherapy Expansion Data for IDE397 a Potential First-in-Class MAT2A Inhibitor in MTAP-Deletion Urothelial and Lung Cancer
• 5 iulie ·

  Yahoo
  IDEAYA Announces Investor Webcast to Report Clinical Data Update for IDE397 Phase 2 Monotherapy Expansion Dose in MTAP-Deletion Urothelial and Lung Cancer on Monday, July 8, 2024
• 26 iunie ·

  Yahoo
  IDEAYA Biosciences initiates subject dosing in Phase I bladder cancer trial
• 25 iunie ·

  Yahoo
  IDEAYA Biosciences Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE397 and Trodelvy® Combination in MTAP-Deletion Bladder Cancer
• 24 iunie ·

  Yahoo
  IDEAYA Biosciences Announces Clinical Program Updates for IDE397 a Potential First-in-Class Phase 2 MAT2A Inhibitor Targeting MTAP-Deletion Solid Tumors
• 20 iunie ·

  Market News Video
  IDEAYA Biosciences Breaks Below 200-Day Moving Average - Notable for IDYA
• 18 iunie ·

  Yahoo
  Investors in IDEAYA Biosciences (NASDAQ:IDYA) have seen impressive returns of 277% over the past five years